PB2288: INCIDENCE OF NEWLY DIAGNOSED AGGRESSIVE NON-HODGKIN’S LYMPHOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN ISRAEL - A SINGLE CENTER RETROSPECTIVE STUDY

por Bronstein, Yotam, Feigin, Eugene, Avivi, Irit, Joffe, Erel, Perry, Chava
Publicado 2023

How we treat mature B-cell neoplasms (indolent B-cell lymphomas)

por Lumish, Melissa, Falchi, Lorenzo, Imber, Brandon S., Scordo, Michael, von Keudell, Gottfried, Joffe, Erel
Publicado 2021

Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study

por Qi, Shunan, Liu, Xin, Noy, Ariela, Lee, Jisun, Teckie, Sewit, Hajj, Carla, Joffe, Erel, Imber, Brandon S., Yahalom, Joachim
Publicado 2022

The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma

por Perry, Chava, Lerman, Hedva, Joffe, Erel, Sarid, Nadav, Amit, Odelia, Avivi, Irit, Kesler, Mikhail, Ben-Ezra, Jonathan, Even-Sapir, Einat, Herishanu, Yair
Publicado 2016

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

por Herishanu, Yair, Avivi, Irit, Aharon, Anat, Shefer, Gabi, Levi, Shai, Bronstein, Yotam, Morales, Miguel, Ziv, Tomer, Shorer Arbel, Yamit, Scarfò, Lydia, Joffe, Erel, Perry, Chava, Ghia, Paolo
Publicado 2021

P1220: EXPLORING TP53 BIOLOGY IN DIFFUSE LARGE B-CELL LYMPHOMA: A GENOMIC AND TRANSCRIPTOMIC META-ANALYSIS

por Uppal, Manik, Lee Batlevi, Connie, Falchi, Lorenzo, Hamlin, Paul, Horwitz, Steven, Kumar, Anita, Noy, Ariela, Zelenetz, Andrew, Arcila, Maria, Dogan, Ahmet, Imber, Brandon, Yahalom, Joachim, Salles, Gilles, Joffe, Erel
Publicado 2023

Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study

por Nowakowski, Grzegorz S., Yoon, Dok Hyun, Peters, Anthea, Mondello, Patrizia, Joffe, Erel, Fleury, Isabelle, Greil, Richard, Ku, Matthew, Marks, Reinhard, Kim, Kibum, Zinzani, Pier Luigi, Trotman, Judith, Huang, Dan, Waltl, Eva E., Winderlich, Mark, Kurukulasuriya, Nuwan C., Ambarkhane, Sumeet, Hess, Georg, Salles, Gilles
Publicado 2022

RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) b...

por Nowakowski, Grzegorz S., Yoon, Dok Hyun, Mondello, Patrizia, Joffe, Erel, Peters, Anthea, Fleury, Isabelle, Greil, Richard, Ku, Matthew, Marks, Reinhard, Kim, Kibum, Zinzani, Pier Luigi, Trotman, Judith, Sabatelli, Lorenzo, Waltl, Eva E., Winderlich, Mark, Sporchia, Andrea, Kurukulasuriya, Nuwan C., Cordoba, Raul, Hess, Georg, Salles, Gilles
Publicado 2023

Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/r...

por Nowakowski, Grzegorz S., Yoon, Dok Hyun, Mondello, Patrizia, Joffe, Erel, Peters, Anthea, Fleury, Isabelle, Greil, Richard, Ku, Matthew, Marks, Reinhard, Kim, Kibum, Zinzani, Pier Luigi, Trotman, Judith, Sabatelli, Lorenzo, Waltl, Eva E., Winderlich, Mark, Sporchia, Andrea, Kurukulasuriya, Nuwan C., Cordoba, Raul, Hess, Georg, Salles, Gilles
Publicado 2023

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

por Haverkos, Bradley, Alpdogan, Onder, Baiocchi, Robert, Brammer, Jonathan E., Feldman, Tatyana A., Capra, Marcelo, Brem, Elizabeth A., Nair, Santosh, Scheinberg, Phillip, Pereira, Juliana, Shune, Leyla, Joffe, Erel, Young, Patricia, Spruill, Susan, Katkov, Afton, McRae, Robert, Royston, Ivor, Faller, Douglas V., Rojkjaer, Lisa, Porcu, Pierluigi
Publicado 2023

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

por Imber, Brandon S., Chau, Karen W., Lee, Jasme, Lee, Jisun, Casey, Dana L., Yang, Joanna C., Wijentunga, N. Ari, Shepherd, Annemarie, Hajj, Carla, Qi, Shunan, Chelius, Monica R., Hamlin, Paul A., Palomba, M. Lia, Joffe, Erel, Zhang, Zhigang, Zelenetz, Andrew D., Salles, Gilles A., Yahalom, Joachim
Publicado 2021

Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting

por Zheng, Serena, Gupta, Kanika, Goyal, Piyush, Nakajima, Reiko, Michaud, Laure, Batlevi, Connie Lee, Hamlin, Paul A., Horwitz, Steven, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Palomba, M. Lia, Straus, David J., Von Keudell, Gottfried, Falchi, Lorenzo, Yahalom, Joachim, Zelenetz, Andrew D., Younes, Anas, Salles, Gilles, Schöder, Heiko, Joffe, Erel
Publicado 2023

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

por Bobillo, Sabela, Joffe, Erel, Sermer, David, Mondello, Patrizia, Ghione, Paola, Caron, Philip C., Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Kumar, Anita, Matasar, Matthew J., Batlevi, Connie L., Moskowitz, Alison, Noy, Ariela, Owens, Collette N., Palomba, M. Lia, Straus, David, von Keudell, Gottfried, Dogan, Ahmet, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas
Publicado 2021

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

por Batlevi, Connie L., Sha, Fushen, Alperovich, Anna, Ni, Ai, Smith, Katy, Ying, Zhitao, Soumerai, Jacob D., Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Owens, Colette, Palomba, Lia M., Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas
Publicado 2020

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

por Sha, Fushen, Okwali, Michelle, Alperovich, Anna, Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Khan, Niloufer, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Noy, Ariela, Owens, Colette, Palomba, Lia M., Rodriguez-Rivera, Ildefonso, Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Yahalom, Joachim, Dogan, Ahmet, Schöder, Heiko, Seshan, Venkatraman E., Salles, Gilles, Younes, Anas, Batlevi, Connie L.
Publicado 2022

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay

por Intlekofer, Andrew M., Joffe, Erel, Batlevi, Connie L., Hilden, Patrick, He, Jie, Seshan, Venkatraman E., Zelenetz, Andrew D., Palomba, M. Lia, Moskowitz, Craig H., Portlock, Carol, Straus, David J., Noy, Ariela, Horwitz, Steven M., Gerecitano, John F., Moskowitz, Alison, Hamlin, Paul, Matasar, Matthew J, Kumar, Anita, van den Brink, Marcel R., Knapp, Kristina M., Pichardo, Janine D., Nahas, Michelle K., Trabucco, Sally E., Mughal, Tariq, Copeland, Amanda R., Papaemmanuil, Elli, Moarii, Mathai, Levine, Ross L., Dogan, Ahmet, Miller, Vincent A., Younes, Anas
Publicado 2018

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

por Stuver, Robert, Shah, Gunjan L., Korde, Neha S., Roeker, Lindsey E., Mato, Anthony R., Batlevi, Connie L., Chung, David J., Doddi, Sital, Falchi, Lorenzo, Gyurkocza, Boglarka, Hamilton, Audrey, Lin, Ya-Hui, Jakubowski, Ann A., Joffe, Erel, Landau, Heather L., Lin, Richard J., Mailankody, Sham, Palomba, M. Lia, Park, Jae H., Perales, Miguel-Angel, Ponce, Doris M., Ramanathan, Lakshmi V., Salles, Gilles A., Scordo, Michael, Seo, Susan K., Shah, Urvi A., Stein, Eytan M., Straus, David, Usmani, Saad Z., Young, James W., Zelenetz, Andrew D., Noy, Ariela, Vardhana, Santosha A.
Publicado 2022